Authors

• Alessandro Salatino (ORCID: https://orcid.org/0000-0001-9241-0768)
• Maurizio Morelli (ORCID: https://orcid.org/0000-0002-7263-1229)
• Angelo Pascarella (ORCID: https://orcid.org/0000-0002-0085-9494)
• Adelaide Greco (ORCID: https://orcid.org/0000-0001-6841-1963)
• Umberto Aguglia (ORCID: https://orcid.org/0000-0002-4574-2951)
• Francesco Brunetti
• Sara Carmela Credendino
• Vincent Huin (ORCID: https://orcid.org/0000-0001-8201-5406)
• Monica Fedele (ORCID: https://orcid.org/0000-0002-9171-1312)
• DANIELA PATRIZIA FOTI (ORCID: https://orcid.org/0000-0002-9536-5736)
• Biagio Arcidiacono (ORCID: https://orcid.org/0000-0003-4343-678X)
• Eusebio Chiefari (ORCID: https://orcid.org/0000-0001-5329-3124)
• Maria Mirabelli (ORCID: https://orcid.org/0000-0002-6427-7186)
• Anna Di Vito (ORCID: https://orcid.org/0000-0002-8294-8684)
• Antonio Brunetti (ORCID: https://orcid.org/0000-0003-1533-8779)
• Giovanna Maria Pierantoni (ORCID: https://orcid.org/0000-0003-4078-8528)
• Ferdinando Nicoletti (ORCID: https://orcid.org/0000-0003-3366-7269)

Institutions

• Inserm (FR)
• Université de Lille (FR)
• Istituto Neurologico Mediterraneo (IT)
• Magna Graecia University (IT)
• Federico II University Hospital (IT)
• Institute for Experimental Endocrinology and Oncology (IT)
• University of Naples Federico II (IT)

Publication Details

Journal

EBioMedicine

Published

2025-04-14

DOI

https://doi.org/10.1016/j.ebiom.2025.105700

Citations

3

Primary Topic

Advanced Glycation End Products research

Type

article

Field-Weighted Citation Impact

3.96

Funders

• Ministero della Salute